-
221
Sex disparities in the association between rare earth elements exposure and genetic mutation frequencies in lung cancer patients
Published 2025-01-01Subjects: Get full text
Article -
222
Six-year performance of risk-based selection for lung cancer screening in the Manchester Lung Health Check cohort
Published 2024-07-01“…Objective Risk prediction models are used to determine eligibility for targeted lung cancer screening. However, prospective data regarding model performance in this setting are limited. …”
Get full text
Article -
223
Epidermal Growth Factor Receptor Gene in Non-Small-Cell Lung Cancer: The Importance of Promoter Polymorphism Investigation
Published 2018-01-01“…In this review, we have summarized some issues considering the role of EGFR in lung cancer, its coding gene, and its promoter gene polymorphisms (SNPs) -216G/T and -191C/A in non-small-cell lung cancer (NSCLC). …”
Get full text
Article -
224
Ensemble machine learning models for lung cancer incidence risk prediction in the elderly: a retrospective longitudinal study
Published 2025-01-01Subjects: “…Lung cancer…”
Get full text
Article -
225
Smoking Cessation by Phone Counselling in a Lung Cancer Screening Program: A Retrospective Comparative Cohort Study
Published 2022-01-01“…Smoking cessation integration within lung cancer screening programs is challenging. Currently, phone counselling is available across Canada for individuals referred by healthcare workers and by self-referral. …”
Get full text
Article -
226
Alkylresorcinols as a New Type of Gut Microbiota Regulators Influencing Immune Therapy Efficiency in Lung Cancer Treatment
Published 2023-01-01“…The content of ARs may influence the response to ICI therapy in lung cancer patients. ARs may be considered regulatory molecules that determine the functioning of antitumor immunity.…”
Get full text
Article -
227
Inhibition of GSK3β is synthetic lethal with FHIT loss in lung cancer by blocking homologous recombination repair
Published 2025-01-01“…FHIT loss is frequently observed in lung cancer, making it an important biomarker for the development of targeted therapy for lung cancer. …”
Get full text
Article -
228
Non-classical pulmonary exacerbation in cystic fibrosis revealing ALK-Translocated lung cancer: A case report
Published 2025-01-01Subjects: “…Non-small cell lung cancer…”
Get full text
Article -
229
Five year mortality in an RCT of a lung cancer biomarker to select people for low dose CT screening.
Published 2025-01-01“…The role of biomarkers in risk-based early detection of lung cancer may enable screening to become cost effective and widely accessible. …”
Get full text
Article -
230
Metastasis-Induced Acute Pancreatitis Successfully Treated with Chemotherapy and Radiotherapy in a Patient with Small Cell Lung Cancer
Published 2015-01-01“…Although involvement of pancreas is a common finding in small cell lung cancer (SCLC), metastasis-induced acute pancreatitis (MIAP) is very rare. …”
Get full text
Article -
231
GTSE1 Facilitates the Malignant Phenotype of Lung Cancer Cells via Activating AKT/mTOR Signaling
Published 2021-01-01“…In conclusion, these results indicated that the overexpressed GTSE1 was involved in the progress of lung cancer by promoting proliferation migration and invasion and inhibiting apoptosis of lung cancer cells via activating AKT/mTOR signaling.…”
Get full text
Article -
232
State of Lung Cancer in Egypt: Moving Towards Improved Guidelines for Prevention, Screening, Treatment, and Clinical Care Programs
Published 2025-01-01Subjects: “…Lung cancer…”
Get full text
Article -
233
miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1
Published 2013-01-01“…MicroRNAs (miRNAs) have been implied to play crucial roles for epithelial-to-mesenchymal transition (EMT) of non-small-cell lung cancer cells (NSCLC cells). Here we found that the expression of miR-149, downregulated in lung cancer, was inversely correlated with invasive capability and the EMT phenotype of NSCLC cells. miR-149 inhibited EMT in NSCLC cells. …”
Get full text
Article -
234
The Frequency of Epidermal Growth Factor Receptor Mutation of Nonsmall Cell Lung Cancer according to the Underlying Pulmonary Diseases
Published 2011-01-01“…Of 198 patients with nonsmall cell lung cancer, we identified 52 (26.3%) patients with an EGFR mutation. …”
Get full text
Article -
235
Awake thoracic surgery for lung cancer treatment: where we are and future perspectives—our experience and review of literature
Published 2025-01-01“…Abstract Background Lung cancer is the first cause of cancer-related death. …”
Get full text
Article -
236
Clinical Significance of the Peripheral Blood Neutrophil-to-Lymphocyte Ratio in Predicting Chemotherapy Outcomes for Small Cell Lung Cancer
Published 2025-01-01Subjects: Get full text
Article -
237
Efficacy of PD-1 blockade plus chemotherapy in patients with oncogenic-driven non-small-cell lung cancer
Published 2025-02-01Subjects: Get full text
Article -
238
Advances in adjuvant therapy for operable N2 non-small cell lung cancer: a narrative review
Published 2025-01-01Subjects: “…non-small cell lung cancer…”
Get full text
Article -
239
Design, Expression, and Inhibitory Effects of Antagonistic Single-Chain Platelet-Derived Growth Factor on Lung Cancer Cells
Published 2025-01-01“…Additionally, MTT assays confirmed the inhibitory effect of the sc-PDGF on lung cancer cells (A549), with an IC50 value of 0.72 µg/ml. …”
Get full text
Article -
240
The correlation between miR-21 single nucleotide polymorphisms and the susceptibility of non-small cell lung cancer
Published 2025-01-01“…Abstract Background There are still gaps in the study of the miRNA and its SNPs in some diseases such as non-small cell lung cancer (NSCLC). The study aimed to provide useful information on the treatment of NSCLC by investigating the association between miR-21 and its SNPs and NSCLC susceptibility. …”
Get full text
Article